Higher Aflibercept Dose Safe as 2 mg

The PULSAR trial of a higher dosage formulation extended the treatment interval to 12 or 16 weeks.

Related Keywords

United Kingdom ,Canada ,Colchester ,Essex ,United States ,Toronto ,Ontario ,American ,David Wong ,Philip Ferrone ,Keyvan Koushan ,Jignesh Patel ,University Of Toronto St ,Colchester Hospitals University Foundation ,American Society Of Retina Specialists ,Toronto Retina Institute ,Annual Meeting ,American Society ,Colchester Hospitals University Foundation Trust ,Vitreoretinal Consultants ,New York ,Antiplatelet Trialists Collaboration ,Retina Specialists ,Presented July ,Retinal Disease ,Macular Degeneration ,Ge Related Macular Degeneration Armd ,Branch Retinal Artery Occlusion ,Exudative Age Related Macular Degeneration ,Xudative Armd ,Eye Problems ,Clinical Research ,Clinical Trials ,Linical Studies ,